Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feedernews.google.com
daratumumab multiple myeloma - Google News
Get the latest updates from daratumumab multiple myeloma - Google News directly as they happen.
Follow now < 10 followers
Latest posts
Last updated over 3 years ago
National Institute for Health and Care Excellence says 'yes' to Darzalex® (daratumumab) for relapsed and refractory multiple myeloma - PharmiWeb.com
over 3 years ago
National Institute for Health and Care Excellence says 'yes' to Darzalex® (daratumumab)...
Sarclisa Extends Survival in Recent Data and Speeds SubQ Administration in Multiple Myeloma - Myeloma Crowd News
over 3 years ago
Sarclisa Extends Survival in Recent Data and Speeds SubQ Administration in Multiple...
Costa Reviews Regimens for Patients With Transplant-Eligible and Transplant-Ineligible NDMM - Targeted Oncology
over 3 years ago
Costa Reviews Regimens for Patients With Transplant-Eligible and Transplant-Ineligible NDMM Targeted Oncology
Life-extending injection for blood cancer made available on NHS - National Health Executive
over 3 years ago
Life-extending injection for blood cancer made available on NHS National Health Executive
Life-extending injection for multiple myeloma available on the NHS - Health Europa
over 3 years ago
Life-extending injection for multiple myeloma available on the NHS Health Europa
A Multiple Myeloma Overview - AJMC.com Managed Markets Network
over 3 years ago
A Multiple Myeloma Overview AJMC.com Managed Markets Network
Sanofi Challenges J&J's Darzalex With Blackstone Pact For SC Sarclisa - Scrip
over 3 years ago
Sanofi Challenges J&J's Darzalex With Blackstone Pact For SC Sarclisa Scrip
NICE says 'yes' to Darzalex for relapsed and refractory MM - The Pharma Letter
over 3 years ago
NICE says 'yes' to Darzalex for relapsed and refractory MM The Pharma...
NHS England » Life-extending injection for blood cancer available on the NHS - NHS England
over 3 years ago
NHS England » Life-extending injection for blood cancer available on the NHS...
Sanofi inks 300 million-euro deal with Blackstone on multiple myeloma - The Pharma Letter
over 3 years ago
Sanofi inks 300 million-euro deal with Blackstone on multiple myeloma The Pharma...
Blackstone funds new trials of Sanofi's Sarclisa in myeloma - - pharmaphorum
over 3 years ago
Blackstone funds new trials of Sanofi's Sarclisa in myeloma - pharmaphorum
Monoclonal Antibody for Multiple Myeloma Market Outlook: Post Covid-19 Scenario by 2029 | Bristol Myers Squibb, Karyopharm Therapeutics, Roche – The Sabre - The Sabre
over 3 years ago
Monoclonal Antibody for Multiple Myeloma Market Outlook: Post Covid-19 Scenario by 2029...